TEVA - Teva wins FDA nod for new Austedo formulation
2024-05-30 07:33:56 ET
More on Teva Pharmaceutical
- Teva Pharmaceutical Industries Limited (TEVA) BofA Securities 2024 Health Care Conference (Transcript)
- Teva Pharmaceutical: 6 Takeaways From Q1 2024 Earnings Results
- Teva: Sustained Revenue Growth Amid Financial Strain (Rating Downgrade)
- ADHD diagnoses increasing, becoming an 'expanding public health concern': CDC
- Teva, Alvotech launch biosimilar against AbbVie’s Humira